The genomic potential of the Aspirin in Reducing Events in the Elderly and Statins in Reducing Events in the Elderly studies

Reclassification of genetic-based risk predictions as GWAS data accumulate

(2016) Joel Krier et al.   Genome Medicine

Deep phenotyping: The details of disease

(2015) Cathryn M. Delude   NATURE

Global implementation of genomic medicine: We are not alone

(2015) Teri A. Manolio et al.   Science Translational Medicine

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

(2015) Cathie Sudlow et al.   PLOS MEDICINE

Statistical power and significance testing in large-scale genetic studies

(2014) Pak C. Sham et al.   NATURE REVIEWS GENETICS

Natural selection and infectious disease in human populations

(2014) Elinor K. Karlsson et al.   NATURE REVIEWS GENETICS

Clues from the resilient

(2014) S. H. Friend et al.   SCIENCE

Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trial

(2013)   Contemporary Clinical Trials

From human genome to cancer genome: The first decade

(2013) D. A. Wheeler et al.   GENOME RESEARCH

Rare-disease genetics in the era of next-generation sequencing: discovery to translation

(2013) Kym M. Boycott et al.   NATURE REVIEWS GENETICS

Pitfalls of predicting complex traits from SNPs

(2013) Naomi R. Wray et al.   NATURE REVIEWS GENETICS

Five Years of GWAS Discovery

(2012) Peter M. Visscher et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Genome-wide association studies of schizophrenia

(2012) Sarah E. Bergen et al.   CURRENT OPINION IN PSYCHIATRY

The Canadian Partnership for Tomorrow Project: building a pan-Canadian research platform for disease prevention

(2010) M. J. Borugian et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL